Contact this trialFirst, we need to learn more about you.
ALK Inhibitor
Alectinib for Lung Cancer
Recruiting1 awardPhase 1 & 2
Columbus, Ohio
This trial will have two parts, Phase 1b and Phase 2. The Phase 1b will happen first, followed by Phase 2. Each cycle of treatment will last 28 days
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.